We'll see what the terms are but we are an early-stage clinical company. That risk robs us of leverage with big money even at our market cap. If we can do another financing like the Perceptive raise that doesn't require sweetening with warrants...that would be a win in my opinion and would continue to show our strength.
AVR Price at posting:
$26.20 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)